Site Details
LOCATION
Hosp. of the Univ. of Pennsylvania CRS
Division of Infectious Diseases and HIV Medicine University College of Medicine
245 North 15th Street, MS461
Philadelphia, PA. 19102
SiteType
CRS
Site Trials
HIV comorbidities and complications
Closed to accrual
A5332: REPRIEVE Trial
In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.